Prognostic factors in adenocarcinoma of the uterine cervix

Gynecologic Oncology

Volumn 92, Issue 1, 2004, Pages 262-267

  Baalbergen, A ^a   Ewing Graham, P C ^b   Hop, W C J ^c   Struijk, P ^c   Helmerhorst, Th J M ^c  

^a REINIER DE GRAAF HOSPITAL   (Netherlands)

^b JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Adenocarcinoma; Cervix; Prognostic factors

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL INVASION; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NETHERLANDS; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; REGISTER; REGRESSION ANALYSIS; REVIEW; STROMA; SURVIVAL RATE; SURVIVAL TIME; UTERINE CERVIX CARCINOMA; UTERINE CERVIX TUMOR;

EID: 0742307254     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2003.09.001     Document Type: Article

References (43)

1. Smith H.O., Tiffany M.F., Qualls C.R., Key C.R. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States - a 24-year population-based study. Gynecol. Oncol. 78:2000;97-105.
2. Alfsen G.C., Kristensen G.B., Skovlund E., Pettersen E.O., Abeler V.M. Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: a population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix. Cancer. 92:2001;2471-2483.
3. Grisaru D., Covens A., Chapman B., Shaw P., Colgan T., Murphy J.et al. Does histology influence prognosis in patients with early-stage cervical carcinoma? Cancer. 92:2001;2999-3004.
4. Liu S., Semenciw R., Mao Y. Cervical cancer: the increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women. CMAJ. 164:2001;1151-1152.
5. Krane J.F., Granter S.R., Trask C.E., Hogan C.L., Lee K.R. Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: a study of 49 cases. Cancer. 93:2001;8-15.
6. Schoolland M., Allpress S., Sterrett G.F. Adenocarcinoma of the cervix. Cancer. 96:2002;5-13.
7. Vizcaino A.P., Moreno V., Bosch F.X., Munoz N., Barros-Dios X.M., Parkin D.M. International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int. J. Cancer. 75:1998;536-545.
8. van der Zee J., Gonzalez Gonzalez D., van Rhoon G.C., van Dijk J.D., van Putten W.L., Hart A.A. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet. 355:2000;1119-1125.
9. Gallup D.G., Harper R.H., Stock R.J. Poor prognosis in patients with adenosquamous cell carcinoma of the cervix. Obstet. Gynecol. 65:1985;416-422.
10. Ireland D., Hardiman P., Monaghan J.M. Adenocarcinoma of the uterine cervix: a study of 73 cases. Obstet. Gynecol. 65:1985;82-85.
11. Kilgore L.C., Soong S.J., Gore H., Shingleton H.M., Hatch K.D., Partridge E.E. Analysis of prognostic features in adenocarcinoma of the cervix. Gynecol. Oncol. 31:1988;137-153.
12. Hopkins M.P., Schmidt R.W., Roberts J.A., Morley G.W. The prognosis and treatment of stage I adenocarcinoma of the cervix. Obstet. Gynecol. 72:1988;915-921.
13. Eifel P.J., Morris M., Oswald M.J., Wharton J.T., Delclos L. Adenocarcinoma of the uterine cervix. Prognosis and patterns of failure in 367 cases. Cancer. 65:1990;2507-2514.
14. Leminen A., Paavonen J., Forss M., Wahlstrom T., Vesterinen E. Adenocarcinoma of the uterine cervix. Cancer. 65:1990;53-59.
15. Attanoos R., Nahar K., Bigrigg A., Roberts S., Newcombe R.G., Ismail S.M. Primary adenocarcinoma of the cervix. A clinicopathologic study of prognostic variables in 55 cases. Int. J. Gynecol. Cancer. 5:1995;179-186.
16. Chen R.J., Lin Y.H., Chen C.A., Huang S.C., Chow S.N., Hsieh C.Y. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan. Gynecol. Oncol. 73:1999;184-190.
17. Waldenstrom A.C., Horvath G. Survival of patients with adenocarcinoma of the uterine cervix in western Sweden. Int. J. Gynecol. Cancer. 9:1999;18-23.
18. Ishikawa H., Nakanishi T., Inoue T., Kuzuya K. Prognostic factors of adenocarcinoma of the uterine cervix. Gynecol. Oncol. 73:1999;42-46.
19. Dijck van J.A.A.M., Coebergh J.W.W., Siesling S., Visser O. Trends of cancer in the Netherlands 1989-1998. 2002;Vereniging van Integrale Kankercentra, Utrecht.
20. Moreno V., Bosch F.X., Munoz N., Meijer C.J., Shah K.V., Walboomers J.M.et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet. 359:2002;1085-1092.
21. Ursin G., Peters R.K., Henderson B.E., d'Ablaing G. III, Monroe K.R., Pike M.C. Oral contraceptive use and adenocarcinoma of cervix. Lancet. 344:1994;1390-1394.
22. Sasieni P., Adams J. Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet. 357:2001;1490-1493.
23. Mathers M.E., Johnson S.J., Wadehra V. How predictive is a cervical smear suggesting glandular neoplasia? Cytopathology. 13:2002;83-91.
24. Hammoud M.M., Haefner H.K., Michael C.W., Ansbacher R. Atypical glandular cells of undetermined significance. Histologic findings and proposed management. J. Reprod. Med. 47:2002;266-270.
25. Ursin G., Pike M.C., Preston-Martin S., d'Ablaing G. III, Peters R.K. Sexual, reproductive, and other risk factors for adenocarcinoma of the cervix: results from a population-based case-control study (California, United States). Cancer Causes Control. 7:1996;391-401.
26. Alfsen G.C., Thoresen S.O., Kristensen G.B., Skovlund E., Abeler V.M. Histopathologic subtyping of cervical adenocarcinoma reveals increasing incidence rates of endometrioid tumors in all age groups: a population based study with review of all nonsquamous cervical carcinomas in Norway from 1966 to 1970, 1976 to 1980, and 1986 to 1990. Cancer. 89:2000;1291-1299.
27. Matthews C.M., Burke T.W., Tornos C., Eifel P.J., Atkinson E.N., Stringer C.A.et al. Stage I cervical adenocarcinoma: prognostic evaluation of surgically treated patients. Gynecol. Oncol. 49:1993;19-23.
28. McLellan R., Dillon M.B., Woodruff J.D., Heatley G.J., Fields A.L., Rosenshein N.B. Long-term follow-up of stage I cervical adenocarcinoma treated by radical surgery. Gynecol. Oncol. 52:1994;253-259.
29. Nakano T., Arai T., Morita S., Oka K. Radiation therapy alone for adenocarcinoma of the uterine cervix. Int. J. Radiat. Oncol. Biol. Phys. 32:1995;1331-1336.
30. Shingleton H.M., Bell M.C., Fremgen A., Chmiel J.S., Russell A.H., Jones W.B.et al. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer. 76:1995;1948-1955.
31. Leveque J., Laurent J.F., Burtin F., Foucher F., Goyat F., Grall J.Y.et al. Prognostic factors of the uterine cervix adenocarcinoma. Eur. J. Obstet. Gynecol. Reprod. Biol. 80:1998;209-214.
32. Silver D.F., Hempling R.E., Piver M.S., Recio F.O., Eltabbakh G.H. Stage I adenocarcinoma of the cervix: does lesion size affect treatment options and prognosis? Am. J. Clin. Oncol. 21:1998;431-435.
33. Schorge J.O., Lee K.R., Lee S.J., Flynn C.E., Goodman A., Sheets E.E. Early cervical adenocarcinoma: selection criteria for radical surgery. Obstet. Gynecol. 94:1999;386-390.
34. Nakanishi T., Ishikawa H., Suzuki Y., Inoue T., Nakamura S., Kuzuya K. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecol. Oncol. 79:2000;289-293.
35. Erzen M., Mozina A., Bertole J., Syrjanen K. Factors predicting disease outcome in early stage adenocarcinoma of the uterine cervix. Eur. J. Obstet. Gynecol. Reprod. Biol. 101:2002;185-191.
36. Samlal R.A.K., van der Velden J., Ketting B.W., Gonzalez Gonzalez D., ten Kate F.J.W., Hart A.A.M.et al. Disease-free interval and recurrence pattern after the Okabayashi variant of Wertheim's radical hysterectomy for stage IB and IIA cervical carcinoma. Int. J. Gynecol. Cancer. 6:1996;120-1207.
37. Hepler T.K., Dockerty M., Randall L.M. Primary adenocarcinoma of the cervix. Am. J. Obstet. Gynecol. 63:1952;800-808.
38. Hurt W.G., Silverberg S.G., Frable W.J., Belgrad R., Crooks L.D. Adenocarcinoma of the cervix: histopathologic and clinical features. Am. J. Obstet. Gynecol. 129:1977;304-315.
39. Landoni F., Maneo A., Colombo A., Placa F., Milani R., Perego P.et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 350:1997;535-540.
40. Hong J.H., Tsai C.S., Wang C.C., Lai C.H., Chen W.C., Lee S.P.et al. Comparison of clinical behaviors and responses to radiation between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas of the cervix. Changgeng Yixue Zazhi. 23:2000;396-404.
41. Cuccia C.A., Bloedorn F.G., Onal M. Treatment of primary adenocarcinoma of the cervix. Am. J. Roentgenol. Radium Ther. Nucl. Med. 99:1967;371-375.
42. Heller P.B., Barnhill D.R., Mayer A.R., Fontaine T.P., Hoskins W.J., Park R.C. Cervical carcinoma found incidentally in a uterus removed for benign indications. Obstet. Gynecol. 67:1986;187-190.
43. Peters W.A. III, Liu P.Y., Barrett R.J., Stock R.J., Monk B.J., Berek J.S.et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J. Clin. Oncol. 18:2000;1606-1613.